CONTEXT: The rupture of atherosclerotic plaque, followed by the formation of an occlusive thrombus, causes nearly all heart attacks and many strokes. Multidetector CT has shown increasing success in the detection of arterial stenoses and differentiation of calcified and soft plaque. It has not, however, been able to detect an important early warning sign of plaque rupture: fibrin-rich microthrombi that develop within microfissures of vulnerable lesions. New research reported at the 2003 annual meeting of the Society for Molecular Imaging suggests that could change.
RESULTS: Patrick M. Winter, Ph.D., Dr. Samuel Wickline, and Dr. Gregory Lanza, of the cardiovascular division at Washington University in St. Louis, worked with researchers from the U.K. and the Netherlands to develop a radio-opaque nanoparticle contrast agent through use of a special iodinated oil. After demonstrating the inherent radio-opacity of the contrast material with CT imaging, they linked antifibrin monoclonal antibodies to the surface of the nanoparticles and added the preparation to plasma clots suspended in saline on a suture line. For comparison, nanoparticulate contrast material without antifibrin antibodies was added to identical plasma clot suspensions.
CT was far better at imaging thrombus when the contrast material consisted of fibrin-targeted nanoparticles: Gray-scale contrast enhancement was significantly greater with fibrin-targeted nanoparticles when compared to unaltered nanoparticles (210 vs. 160; p < 0.05). Contrast-to-noise ratios were markedly greater as well (22 vs. 5; p < 0.05).
IMPLICATIONS: This study shows for the first time that a fibrin-specific molecular imaging agent can increase the sensitivity of CT for the detection of thrombus. This technique may spur early detection and localization of vulnerable plaques, perhaps enabling their treatment during routine cardiac catheterization or intervention.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.